Krystal Biotech Inc.

NASDAQ: KRYS · Real-Time Price · USD
150.42
0.09 (0.06%)
At close: Aug 15, 2025, 3:59 PM
150.27
-0.10%
After-hours: Aug 15, 2025, 05:36 PM EDT

Krystal Biotech Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
89.16M 10.93M -139.97M -69.57M
Depreciation & Amortization
6.71M 5.01M 4.05M 2.77M
Stock-Based Compensation
49.13M 39.93M 33.23M 15.32M
Other Working Capital
59.15M 8.73M 4.07M 1.34M
Other Non-Cash Items
-7.12M -106.79M -690K 1.49M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-14.46M -37.88M 2.81M 2.05M
Operating Cash Flow
123.42M -88.8M -100.57M -47.94M
Capital Expenditures
-4.24M -11.8M -52.98M -68.34M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-457.74M -508.78M -318.78M -190.46M
Sales Maturities Of Investments
298.54M 503.21M 257.68M 32.03M
Other Investing Acitivies
n/a 100M n/a n/a
Investing Cash Flow
-163.44M 82.64M -114.08M -226.77M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
27.01M -749K -649K -7.96M
Financial Cash Flow
27.01M 202.75M 35.35M 347.69M
Net Cash Flow
-13.46M 196.43M -179.35M 72.98M
Free Cash Flow
119.18M -100.6M -153.55M -116.27M